Justin J. McAnear - Feb 22, 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Financial Officer
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Stock symbol
TXG
Transactions as of
Feb 22, 2022
Transactions value $
-$22,637
Form type
4
Date filed
2/24/2022, 06:38 PM
Previous filing
Jan 5, 2022
Next filing
Mar 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale -$22.6K -288 -0.74% $78.60 38.5K Feb 22, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.